Denali Therapeutics (DNLI)_個股概要_股票價格_行情走勢圖_Moomoo

自選
模擬交易
選股器
熱力圖
機構追踪

美股市場個股詳情

DNLI Denali Therapeutics

添加自選

17.140
+0.330+1.96%

收盤價 05/03 16:00 (美東)

17.170
+0.030+0.18%

盤後 16:53 (美東)

24.43億總市值-16169市盈率TTM

全部分時

5日
日K
周K
月K
季K
年K

資金分布

單位: --

資金流向

實時日周月

暫無數據

新聞

評論

專欄Biotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

6

Denali Therapeutics' continuous stock price drop questions the initial investment decision. The company's struggle to increase revenue while unprofitable worries investors. Despite a recent 3.9% rise, the company's disappointing performance over the past years resulted in a yearly 3% total loss for shareholders over five years.

Denali Therapeutics (NASDAQ:DNLI) Shareholders Are up 3.9% This Past Week, but Still in the Red Over the Last Three Years

$Denali Therapeutics(DNLI.US)$ 👀

2

Ph2 readouts in Q1 2024...

$輝瑞(PFE.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$阿里拉姆制藥(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...

Ph2 readouts in Q1 2024...

23

Upcoming Ph 2 readouts in Q1 2024…

$Cellectar BioSciences(CLRB.US)$ Phase 2
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$阿里拉姆制藥(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...

Upcoming Ph 2 readouts in Q1 2024…

36

6

閱讀更多

分析

分析師評級

暫無數據

目標價預測

暫無數據

美股

綜合熱度